Plain-English translation of NCT04483804 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Researchers want to understand whether special ultrasound images—including standard ultrasound, elastography (which measures tissue stiffness), and contrast-enhanced ultrasound—can help predict how breast cancer will progress. This trial will collect ultrasound images and compare them to pathology results (what doctors find when examining tissue under a microscope) to see if imaging patterns can reliably forecast patient outcomes.
Right now, doctors don't know much about how ultrasound imaging patterns connect to the features that actually predict whether a patient's cancer will return or spread. This research aims to fill that gap so ultrasound could become a better tool for predicting outcomes and guiding treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you join, you will undergo specialized ultrasound scans (including elastography and contrast-enhanced ultrasound) as part of the study. Researchers will compare these images to your pathology results and track your health outcomes over time to see how well the ultrasound patterns predict whether your cancer returns or progresses. The study is enrolling up to 2,000 participants and is currently recruiting.
AI-generated summary from trial data · Sep 1, 2026 · Not medical advice
China
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Enrollment target
~2,000 participants
Started
January 2018
Primary completion
December 2023
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in March 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
zimei Lin
Second Affiliated Hospital, Zhejiang University, School of Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.